New techniques in imaging of brain activity developed by Jean Gotman and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination of electroencephalogram and functional magnetic resonance imaging leads to more precise localization of the areas generating epileptic seizures, giving neurosurgeons a better understanding of the optimal ways of intervention, if appropriate.
TEL AVIV, Israel, May 23, 2013 /PRNewswire/ -- Israel Brain Technologies (IBT) has announced the launch of BrainTech Israel 2013, Israel's 1st International Brain Technology Conference, which will take place on October 14th-15th in Tel Aviv, recently ranked as the 2nd most innovative...
New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy SystemMay 21, 2013 5:00 pm | by PR Newswire | News | Comments
SAN FRANCISCO, May 21, 2013 /PRNewswire/ -- New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System® induced statistically and clinically meaningful response and remission in patients with Major Depressive...
A new study looking at sleep-disordered breathing and markers for Alzheimer's disease risk in cerebrospinal fluid and neuroimaging adds to the growing body of research linking the two. But this latest study also poses an interesting question: Could AD in its "preclinical stages" also lead to SDB and explain the increased prevalence of SDB in the elderly?
The Ohio State University Commences Key Comparative Study of Vycor's Patented ViewSite Brain Access SystemMay 20, 2013 8:30 am | by The Associated Press | News | Comments
Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a medical device company with a suite of FDA approved products, announced today that the Minimally Invasive Cranial Surgery Program at the Ohio State University (Columbus, OH) has commenced an animal study to evaluate a comparison of tissue damage...
Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device (MD) trail evaluations are much more complicated than drug trails due to their unique clinical practices....
A new tool being developed by UT Arlington assistant professor of physics could help scientists map and track the interactions between neurons inside different areas of the brain. The journal Optics Letters recently published a paper by Samarendra Mohanty on the development of a fiber-optic, two-photon, optogenetic stimulator and its use on human cells in a laboratory.
ZURICH & DUESSELDORF, Germany--(BUSINESS WIRE)--May 16, 2013--The fifth annual EuroMedtech™ partnering conference concluded last week in Duesseldorf, Germany. EuroMedtech is Europe’s leading medical technology partnering conference where participants engage with potential partners around in-...
UCB and IBM today announced the completion of the initial phase of a project designed to harness the power of analytics to help healthcare providers deliver more highly personalized care to people living with epilepsy. The milestone marks the critical first step in the path towards eventually harnessing the transformative power of cognitive computing capabilities, such as IBM Watson, for epilepsy care.
The government has halted a study testing treatments for a brain condition that can cause strokes after early results suggested invasive therapies were riskier than previously thought. The condition involves a kind of tangle in the brain called an arteriovenous malformation, or AVM. Arteries and veins grow knotted together until eventually some of them burst, causing a bleeding stroke.
It’s no secret that getting a medical device to market can be a lengthy, frustrating process. Facing the new medical device excise tax and lack of clarity from the FDA around regulatory policies, medtech startups are now starting to rethink launching in the U.S.
Life Care Medical Devices Ltd (OTCBB:LCMD) today announced the opening of their European subsidiary offices in Dublin, Ireland. Life Care Medical Devices Ltd, Ireland will manage all aspects of the company's European business. "With a strong, solid history in the medical device arena,...
Wireless healthcare is upon us. Each day, it seems more devices and technology are becoming untethered or new capabilities are being added to wireless devices. No longer are the applications of wireless devices limited to patient monitoring, but rather an array of therapies are now available for treating patients at home or even on the go.
Adults with depression and who receive certain types of anti-depressants have an increased risk of developing Clostridium difficile, a costly and serious hospital-associated infection, according to a new University of Michigan Health System study.
Unique energy-based surgical devices afford broad clinical use in the cutting, coagulation, and ablation of tissues using a high velocity jet of thermal plasma, and the PlasmaJet surgical system is one example of this medical device evolution. Plasma is formed when sufficient energy is added to remove outer electrons from a gas to form ions.
Electroconvulsive therapy is the most effective acute treatment for severe major depression. However, even with newer forms of ECT, there remains a significant risk of adverse cognitive effects, particularly memory problems. Current theories hold that the regions that need to be stimulated to treat the depression are different and separate from the regions that result in memory problems.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory.
Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism. The new model cell system allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.
Normal vision is essentially a spatial sense that often relies upon touch and movement during and after development, there is often a correlation between how an object looks and how it feels. Moreover, as a child's senses develop, there is cross-referencing between the various senses.
Study Demonstrates Significant Pain Reduction with DFINE Star Tumor Ablation System in Spinal MetastasesMay 1, 2013 4:40 pm | by DFINE, Inc. | News | Comments
DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, released study results highlighting the clinical benefits of advanced Targeted-Radiofrequency Ablation™ (t-RFA) therapy for the management of patients experiencing painful spinal lesions.
The newly reformatted MD&M East four day conference running alongside the tradeshow, covers everything you need to know from concept development to supplier management, giving you the essential updates to successfully management every step in the product development efficiently and cost effectively.
Georgia Institute of Technology bioengineering PhD student Teresa Sanders was working with Emory University Parkinson’s Disease specialists, and received an eZ430-Chronos watch from TI. She had a thought: A watch with an accelerometer could measure limb tremors and be paired with other tools to assess patients with Parkinson’s disease.
WASHINGTON , April 29, 2013 /PRNewswire-USNewswire/ -- Most children with isolated skull fractures may not need to stay in the hospital, which finding has the potential to save the health care system millions of dollars a year ("Isolated Skull Fractures: Trends in Management in U.S. Pediatric Emergency Departments"). In addition, a new device more accurately estimates children's we...
PLYMOUTH, Minn.--(BUSINESS WIRE)--Apr 29, 2013--Monteris Medical announced that their First-In-Humans clinical trial with the NeuroBlate ® System for neurosurgical ablation has been published in the Journal of Neurosurgery. This study was a thermal dose-escalation trial to assess the safety and...
athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, in partnership with MIT's H@cking Medicine, invites the health care, technology and scientific communities to participate in a Hack-a-Thon on May 4 and 5 at athenahealth's headquarters in Watertown, Mass.